scispace - formally typeset
Open AccessJournal ArticleDOI

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: A combined analysis of 12 mathematical models

Jeffrey W. Eaton, +59 more
- 01 Jan 2014 - 
- Vol. 2, Iss: 1, pp 23-34
Reads0
Chats0
TLDR
Estimates suggest that earlier eligibility for antiretroviral therapy is very cost effective in low-income and middle-income settings, although these estimates should be revisited when more data become available.
About
This article is published in The Lancet Global Health.The article was published on 2014-01-01 and is currently open access. It has received 217 citations till now. The article focuses on the topics: Eligibility Determination & Cost effectiveness.

read more

Citations
More filters
Journal ArticleDOI

Initiation of antiretroviral therapy in early asymptomatic HIV infection

TL;DR: The initiation of antiretroviral therapy in HIV-positive adults with a CD4+ count of more than 500 cells per cubic millimeter provided net benefits over starting such therapy in patients after the CD4+, but the risks of unscheduled hospital admissions were similar in the two groups.
Journal ArticleDOI

Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa.

TL;DR: Reduced access to healthcare during the Epstein-Barr virus outbreak substantially increased mortality rates from other diseases.
References
More filters
Journal ArticleDOI

Prevention of HIV-1 infection with early antiretroviral therapy

TL;DR: The exciting evidence generated by this paper – that antiretroviral treatment of HIV-1 infection definitively reduces the risk of onward transmission of the virus by 96% – was rightly dubbed Science magazine's ‘Breakthrough of the Year’ in 2011.
Related Papers (5)